These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6112274)

  • 1. Toxic epidermal necrolysis, agranulocytosis and erythroid hypoplasia associated with sulphasalazine.
    Maddocks JL; Slater DN
    J R Soc Med; 1980 Aug; 73(8):587-8. PubMed ID: 6112274
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythroderma and toxic epidermal necrolysis caused by to 5-aminosalacylic acid.
    Iemoli E; Piconi S; Ardizzone S; Bianchi Porro G; Raimond F
    Inflamm Bowel Dis; 2006 Oct; 12(10):1007-8. PubMed ID: 17012974
    [No Abstract]   [Full Text] [Related]  

  • 3. Stevens-Johnson syndrome with sulfasalazine treatment: report of two cases.
    Tremblay L; Pineton de Chambrun G; De Vroey B; Lavogiez C; Delaporte E; Colombel JF; Cortot A
    J Crohns Colitis; 2011 Oct; 5(5):457-60. PubMed ID: 21939920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfasalazine-induced agranulocytosis.
    Jacobson IM; Kelsey PB; Blyden GT; Demirjian ZN; Isselbacher KJ
    Am J Gastroenterol; 1985 Feb; 80(2):118-21. PubMed ID: 2857524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of sulphasalazine-induced agranulocytosis with granulocyte macrophage-colony stimulating factor.
    Roddie P; Dorrance H; Cook MK; Rainey JB
    Aliment Pharmacol Ther; 1995 Dec; 9(6):711-2. PubMed ID: 8824661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Life threatening agranulocytosis and toxic epidermal necrolysis during low dose penicillamine therapy.
    Ward K; Weir DG
    Ir J Med Sci; 1981 Aug; 150(8):252-3. PubMed ID: 7287366
    [No Abstract]   [Full Text] [Related]  

  • 8. Toxic Epidermal Necrolysis in a Pediatric Patient.
    Hagen S; Grey K; Hylwa S
    Minn Med; 2016; 99(3):49-50. PubMed ID: 27323526
    [No Abstract]   [Full Text] [Related]  

  • 9. [Salicylazosulfapyridine-induced agranulocytosis in a patient with ulcerative colitis, successfully treated with granulocyte colony-stimulating factor].
    Matsubayashi Y; Izumi Y; Mori Y; Itoh K; Morioka A; Tatsuta H; Hashimoto A; Kotera T; Itoh A; Jo I
    Nihon Shokakibyo Gakkai Zasshi; 1991 Jan; 88(1):87-90. PubMed ID: 1709218
    [No Abstract]   [Full Text] [Related]  

  • 10. [Agranulocytosis in patients with ulcerative colitis treated with salazosulphapyridine].
    Søndergaard JO; Stage JG; Sprechler M
    Ugeskr Laeger; 1983 Jul; 145(29):2225-7. PubMed ID: 6137093
    [No Abstract]   [Full Text] [Related]  

  • 11. Salazosulphapyridine-related Stevens-Johnson Syndrome Caused by Sulphapyridine and Confirmed by Enzyme-linked Immunospot Assay.
    Xiong H; Chen S; Luo X
    J Crohns Colitis; 2018 Feb; 12(3):381-382. PubMed ID: 29126103
    [No Abstract]   [Full Text] [Related]  

  • 12. [Remission for a patient with ulcerative colitis after agranulocytosis by the side effect of salazosulfapyridine].
    Nakamura K; Takeshima F; Shiozawa K; Furusu H; Tomonaga M; Isomoto H; Ohmagari K; Mizuta Y; Murase K; Kohno S
    Nihon Naika Gakkai Zasshi; 2000 Jan; 89(1):139-41. PubMed ID: 10723929
    [No Abstract]   [Full Text] [Related]  

  • 13. [Stevens-Johnson syndrome in a patient with positive lymphocyte transformation test].
    Carvajal-Elizondo M; Monge-Ortega OP; Chinchilla-Monge R; Quiros S
    Rev Alerg Mex; 2023 May; 70(1):38-42. PubMed ID: 37566754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-dependent binding of circulating antibodies in drug-induced toxic epidermal necrolysis.
    Hensen EJ; Claas FH; Vermeer BJ
    Lancet; 1981 Jul; 2(8238):151-2. PubMed ID: 6113511
    [No Abstract]   [Full Text] [Related]  

  • 15. Sulphasalazine induced agranulocytosis in a patient with rheumatoid arthritis.
    Murphy PT; O'Donnell JR
    Ir J Med Sci; 1990 Jun; 159(6):195. PubMed ID: 1977725
    [No Abstract]   [Full Text] [Related]  

  • 16. Adverse reactions to salicylazosulfapyridine (azulfidine) in the treatment of ulcerative colitis.
    Collins JR
    South Med J; 1968 Apr; 61(4):354-8. PubMed ID: 4384520
    [No Abstract]   [Full Text] [Related]  

  • 17. [Side effects of salicylazosulfapyridine therapy].
    Miller B
    Dtsch Med Wochenschr; 1980 Nov; 105(46):1596-7. PubMed ID: 6108200
    [No Abstract]   [Full Text] [Related]  

  • 18. Toxic epidermal necrolysis and agranulocytosis: rare adverse effects of ciprofloxacin.
    Upadya GM; Ruxana K
    Indian J Med Sci; 2009 Oct; 63(10):461-3. PubMed ID: 19901485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfasalazine-Induced Toxic Epidermal Necrolysis: A Challenging Case During the COVID-19 Pandemic.
    Shahidi-Dadras M; Shahrigharahkoshan S; Yazdi E; Fatemi A; Mahboubi-Fooladi Z; Dadkhahfar S
    Adv Emerg Nurs J; 2021 Jul-Sep 01; 43(3):194-197. PubMed ID: 34397495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfasalazine hypersensitivity with hepatotoxicity, thrombocytopenia, and erythroid hypoplasia.
    Gremse DA; Bancroft J; Moyer MS
    J Pediatr Gastroenterol Nutr; 1989 Aug; 9(2):261-3. PubMed ID: 2572687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.